Autologous mesenchymal stem cell therapy (Sapporo University/ Nipro)

自体间充质干细胞疗法（札幌医科大学/ 尼普洛）

Report date: 2024/01/11 13:34:36

Base Information

Drug NameAutologous mesenchymal stem cell therapy (Sapporo University/ Nipro)
Drug Alias NameStemiracSTR-01
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsSpinal Cord Injuries
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2018/12/28
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSapporo Medical UniversityNipro Corp
China Registration ClassN/A

Develop Information

Active CompaniesNipro Corp
Inactive CompaniesN/A
Active IndicationsSpinal Cord Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A